Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Reshma Kewalramani. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Reshma Kewalramani har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:VRTX / Vertex Pharmaceuticals Incorporated CEO & President, Director 115.968
Director 186.002
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Reshma Kewalramani. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Reshma Kewalramani som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 5.710 115.968 5,18 389,95 2.226.614 45.221.722
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4.290 110.258 4,05 389,08 1.669.153 42.899.183
2025-02-28 2025-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -14.079 105.915 -11,73 479,61 -6.752.429 50.797.893
2025-02-26 2025-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.386 119.994 -7,25 483,28 -4.536.066 57.990.700
2025-02-19 2025-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -6.553 129.380 -4,82 463,46 -3.037.053 59.962.455
2025-02-14 2025-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 19.015 135.933 16,26
2025-02-12 2025-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.300 116.918 -6,63 467,98 -3.884.234 54.715.286
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20.328 125.218 19,38
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.118 104.890 38,43
2024-11-12 2024-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.198 75.772 -16,71 515,00 -7.826.970 39.022.580
2024-08-01 2024-07-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.202 90.970 -14,32 505,00 -7.677.010 45.939.850
2024-07-24 2024-07-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.202 106.172 -12,52 497,00 -7.555.394 52.767.484
2024-06-14 2024-06-12 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 105.263 186.002 130,37
2024-05-29 2024-05-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.565 121.374 -1,27 457,00 -715.205 55.467.918
2024-05-29 2024-05-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.565 122.939 1,29 187,53 293.484 23.054.751
2024-05-22 2024-05-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.202 121.374 -11,13 447,00 -6.795.294 54.254.178
2024-02-27 2024-02-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.386 136.507 -6,43 431,79 -4.052.781 58.942.358
2024-02-21 2024-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -7.019 145.893 -4,59 420,58 -2.952.051 61.359.678
2024-02-21 2024-02-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.359 152.912 -5,77 424,01 -3.968.310 64.836.217
2024-02-13 2024-02-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.255 162.271 -4,84 422,74 -3.489.719 68.598.443
2024-02-08 2024-02-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20.327 170.526 13,53
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26.972 150.199 21,89
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14.516 123.227 13,35
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -17.135 108.711 -13,62 407,00 -6.973.945 44.245.377
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 14.077 125.846 12,59 187,53 2.639.860 23.599.900
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.058 111.769 2,81 155,57 475.733 17.387.903
2023-12-15 2023-12-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.098 108.711 -4,48 397,00 -2.023.906 43.158.267
2023-11-15 2023-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.097 113.809 -4,29 377,00 -1.921.569 42.905.993
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.828 118.906 -6,18 355,00 -2.778.940 42.211.630
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -38 126.652 -0,03 340,19 -12.927 43.085.744
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.668 126.690 -1,30 339,43 -566.169 43.002.387
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.611 128.358 -1,24 338,69 -545.630 43.473.571
2023-02-28 2023-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.386 129.969 -6,74 289,12 -2.713.680 37.576.637
2023-02-22 2023-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.359 139.355 -6,29 292,85 -2.740.783 40.810.112
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -5.990 148.714 -3,87 298,26 -1.786.577 44.355.438
2023-02-14 2023-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.372 154.704 -2,13 294,33 -992.481 45.534.028
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26.972 158.076 20,57
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.118 131.104 28,55
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.388 101.986 13,83
2023-01-27 2023-01-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 89.598 -10,04 315,05 -3.150.500 28.227.850
2022-11-10 2022-09-30 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 9.818 80.739 13,84
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.689 99.598 -10,50 305,06 -3.565.846 30.383.366
2022-06-28 2022-06-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.689 111.153 -9,52 291,30 -3.405.006 32.378.869
2022-06-13 2022-06-10 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
A - Award 70.921 70.921
2022-02-28 2022-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -7.246 122.842 -5,57 227,86 -1.651.074 27.990.778
2022-02-22 2022-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.584 130.088 -6,19 232,51 -1.995.866 30.246.761
2022-02-14 2022-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.031 138.672 -2,14 237,74 -720.590 32.967.881
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.117 141.703 25,86
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.032 112.586 34,75
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9.800 83.554 13,29
2021-11-23 2021-11-19 4 DNA Ginkgo Bioworks Holdings, Inc.
Restricted Stock Units
A - Award 9.818 9.818
2021-09-20 2021-09-16 4 DNA Ginkgo Bioworks Holdings, Inc.
Stock Option
A - Award 17.649 17.649
2021-09-20 2021-09-16 4 DNA Ginkgo Bioworks Holdings, Inc.
Stock Option
A - Award 51.782 51.782
2021-08-23 2021-08-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4.243 73.754 6,10 196,34 833.071 14.480.860
2021-08-23 2021-08-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 5.757 69.511 9,03 195,14 1.123.421 13.564.377
2021-02-26 2021-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.898 63.643 -4,36 217,57 -630.518 13.846.808
2021-02-19 2021-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.080 66.541 -3,03 211,75 -440.440 14.090.057
2021-02-12 2021-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.962 68.621 -4,14 214,16 -634.342 14.695.873
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.031 71.583 68,22
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.388 42.552 41,07
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3.516 30.164 13,19
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -509 3.058 -14,27
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.564 15.642 -9,09
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -93 26.626 -0,35 273,27 -25.414 7.276.087
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -487 26.719 -1,79 272,76 -132.834 7.287.874
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -471 27.206 -1,70 271,42 -127.839 7.384.253
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -870 27.677 -3,05 270,36 -235.213 7.482.754
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -152 28.547 -0,53 269,11 -40.905 7.682.283
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 509 28.699 1,81 155,57 79.185 4.464.703
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.564 28.190 5,87 187,53 293.297 5.286.471
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9 26.626 -0,03 288,37 -2.595 7.678.140
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -19 26.635 -0,07 287,63 -5.465 7.661.025
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -27 26.654 -0,10 286,07 -7.724 7.624.910
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10 26.681 -0,04 283,76 -2.838 7.571.001
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4 26.691 -0,01 282,74 -1.131 7.546.613
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6 26.695 -0,02 281,74 -1.690 7.521.049
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9 26.701 -0,03 280,47 -2.524 7.488.829
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7 26.710 -0,03 279,70 -1.958 7.470.787
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6 26.717 -0,02 276,40 -1.658 7.384.579
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2 26.723 -0,01 274,37 -549 7.331.990
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -510 3.567 -12,51
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.564 17.206 -8,33
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -134 26.626 -0,50 275,17 -36.873 7.326.676
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -864 26.760 -3,13 274,04 -236.771 7.333.310
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -360 27.624 -1,29 272,77 -98.197 7.534.998
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 27.984 -1,06 271,92 -81.576 7.609.409
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -416 28.284 -1,45 270,35 -112.466 7.646.579
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 510 28.700 1,81 155,57 79.341 4.464.859
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.564 28.190 5,87 187,53 293.297 5.286.471
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -111 26.626 -0,42 239,13 -26.543 6.367.075
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -420 26.737 -1,55 238,28 -100.078 6.370.892
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -320 27.157 -1,16 236,71 -75.747 6.428.333
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -340 27.477 -1,22 235,36 -80.022 6.466.987
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -660 27.817 -2,32 234,41 -154.711 6.520.583
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -440 28.477 -1,52 232,35 -102.234 6.616.631
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -450 28.917 -1,53 230,88 -103.896 6.676.357
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -893 29.367 -2,95 229,72 -205.140 6.746.187
2020-02-26 2020-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.898 30.260 -8,74 239,23 -693.289 7.239.100
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -129 33.158 -0,39 245,75 -31.702 8.148.578
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -260 33.287 -0,78 244,94 -63.684 8.153.318
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -134 33.547 -0,40 243,76 -32.664 8.177.417
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -540 33.681 -1,58 242,62 -131.015 8.171.684
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -120 34.221 -0,35 241,71 -29.005 8.271.558
2020-02-19 2020-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -944 34.341 -2,68 241,50 -227.976 8.293.352
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -510 4.077 -11,12
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.564 18.770 -7,69
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -129 35.285 -0,36 242,47 -31.279 8.555.554
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -271 35.414 -0,76 240,75 -65.243 8.525.920
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -423 35.685 -1,17 239,69 -101.389 8.553.338
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.251 36.108 -3,35 238,76 -298.689 8.621.146
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -510 37.359 -1,35 155,57 -79.341 5.811.940
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -1.564 36.849 -4,07 187,53 -293.297 6.910.293
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.387 35.285 54,10
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9.800 22.898 74,82
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy)
M - Exercise -4.692 20.334 -18,75
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.692 13.098 -26,37 219,37 -1.029.284 2.873.308
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4.692 17.790 35,82 187,53 879.891 3.336.159
2019-11-19 2019-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -61 13.098 -0,46 205,95 -12.563 2.697.533
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -509 4.587 -9,99
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -509 13.098 -3,74 199,00 -101.291 2.606.502
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 509 13.607 3,89 155,57 79.185 2.116.841
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3.057 5.096 -37,50
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.057 13.098 -18,92 199,00 -608.343 2.606.502
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.057 16.155 23,34 155,57 475.577 2.513.233
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -638 13.098 -4,64 189,00 -120.582 2.475.522
2019-05-17 2019-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -241 13.736 -1,72 165,41 -39.864 2.272.072
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 13.736 -0,72 188,49 -18.849 2.589.099
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -202 13.836 -1,44 187,27 -37.829 2.591.068
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.186 14.038 -7,79 186,75 -221.486 2.621.596
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 25.026 25.026
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9.799 15.224 180,63
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3.516 5.425 184,18
2018-10-09 2018-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.305 1.909 -54,70 186,95 -430.920 356.888
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.428
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.428
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.428
2018-04-02 3/A VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
4.214
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)